PTC Therapeutics | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Alnylam Pharmaceuticals USD 295.34M 74.35M 2024-12
Amgen USD 1.88B 253M 2024-12
Biogen USD 677.3M 99.6M 2024-12
BioMarin Pharmaceutical USD 256.77M 46.81M 2024-12
Cytokinetics USD 62.34M 5.69M 2024-12
Daiichi Sankyo JPY 185.63B 23.39B 2024-12
Gilead Sciences USD 1.86B 451M 2024-12
Incyte USD 326.71M 17.5M 2024-12
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Novartis USD 3.5B 368M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
PTC Therapeutics USD 84.68M 11.23M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
TG Therapeutics USD 38.96M 3M 2024-12
Ultragenyx Pharmaceutical USD 82.49M 2.14M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Xencor USD 14.92M 148K 2024-12



PTC Therapeutics Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.